Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colonic Neoplasms 7Colorectal Neoplasms 6Rectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Liver Neoplasms 2Head and Neck Neoplasms 2Hand-Foot Syndrome 2Adenomatous Polyposis Coli 2Smoking 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Lung Neoplasms 1Influenza, Human 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms, Male 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

Starch 1Oseltamivir 1Influenza Vaccines 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Influenza, Human × Celecoxib × Clear all
NCT02108366 2019-10-21

Treatment of Severe Influenza A Infection

The University of Hong Kong

Phase 3 Completed
107 enrolled
Lymphoid

Influenza, Human, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡